Germany Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
Summary
Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The German biotechnology market had total revenues of $27.2 billion in 2021, representing a compound annual growth rate (CAGR) of 24% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $13.5 billion, equivalent to 49.7% of the market's overall value.
- The successful performance of the German market has historically been fueled by a strong private and public financial backing, a trend which has been accelerated in 2020 and 2021 as the COVID-19 pandemic has attracted significant investment in the global race to develop effective solutions to control the outbreak and protect citizens.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts
- What was the size of the Germany biotechnology market by value in 2021?
- What will be the size of the Germany biotechnology market in 2026?
- What factors are affecting the strength of competition in the Germany biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Germany's biotechnology market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive Landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the strengths of leading players?
- 7.4. What has been the rationale behind recent M&A activity?
- 8 Company Profiles
- 8.1. Bayer AG
- 8.2. Boehringer Ingelheim GmbH
- 8.3. BioNTech SE
- 8.4. Merck & Co., Inc.
- 8.5. MorphoSys AG
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Germany biotechnology industry value: $ billion, 2016–21
- Table 2: Germany biotechnology industry category segmentation: % share, by value, 2016–2021
- Table 3: Germany biotechnology industry category segmentation: $ billion, 2016-2021
- Table 4: Germany biotechnology industry geography segmentation: $ billion, 2021
- Table 5: Germany biotechnology industry value forecast: $ billion, 2021–26
- Table 6: Bayer AG: key facts
- Table 7: Bayer AG: Annual Financial Ratios
- Table 8: Bayer AG: Key Employees
- Table 9: Bayer AG: Key Employees Continued
- Table 10: Boehringer Ingelheim GmbH: key facts
- Table 11: Boehringer Ingelheim GmbH: Key Employees
- Table 12: BioNTech SE: key facts
- Table 13: BioNTech SE: Annual Financial Ratios
- Table 14: BioNTech SE: Key Employees
- Table 15: Merck & Co., Inc.: key facts
- Table 16: Merck & Co., Inc.: Annual Financial Ratios
- Table 17: Merck & Co., Inc.: Key Employees
- Table 18: Merck & Co., Inc.: Key Employees Continued
- Table 19: MorphoSys AG: key facts
- Table 20: MorphoSys AG: Key Employees
- Table 21: Germany size of population (million), 2017–21
- Table 22: Germany gdp (constant 2005 prices, $ billion), 2017–21
- Table 23: Germany gdp (current prices, $ billion), 2017–21
- Table 24: Germany inflation, 2017–21
- Table 25: Germany consumer price index (absolute), 2017–21
- Table 26: Germany exchange rate, 2017–21
- List of Figures
- Figure 1: Germany biotechnology industry value: $ billion, 2016–21
- Figure 2: Germany biotechnology industry category segmentation: $ billion, 2016-2021
- Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2021
- Figure 4: Germany biotechnology industry value forecast: $ billion, 2021–26
- Figure 5: Forces driving competition in the biotechnology industry in Germany, 2021
- Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2021
- Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2021
- Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2021
- Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2021
- Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2021
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook